Viral Vector GMP Manufacturing
ABL Europe
ABL Europe SAS is a pure-play GMP CMO, completely dedicated to the provision of viral vector GMP contract manufacturing services and a subsidiary of ABL Inc. under the corporate (private) ownership of Institut Mérieux. Formed by the acquisition of Transgene’s GMP manufacturing facilities, ABL has a particularly strong technical & regulatory track record in process development, scale-up & GMP manufacturing of oncolytic and immunotherapeutic viral vectors.
Process Validation
ABL draws on its expertise & experience to design production processes that optimize product yields, minimize regulatory risk & speed the time to clinic.
Quality Control
ABL Europe has a particularly strong in-house analytical function providing a wide range of viral vector product specific QC methods in addition to generic pharmacopeia procedures.
GMP Manufacturing
With a brand new 200 L stirred single use bioreactor (SUB) facility, ABL has strengthened its position in the GMP viral vector CMO market to support clients
Fill / Finish
ABL Europe provides viral vector aseptic drug product manufacturing services in-house using a Bausch and Straubel filling machine located in a rigid isolator.
4 Rue Laurent Fries
67400 Illkirch-Graffenstaden
FRANCE
Phone: +33 3 88 55 10 00
E-Mail Us
For directions and a map of our Strasbourg facility, click here.
317 avenue Jean Jaurès
69007 LYON
FRANCE
